This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

10 Stocks to Watch: PTIE, PFE, SUG

Stocks in this article: ORCLSUGPTIEPFEMUGOOGAEGRBSXACNBBBBWMB


NEW YORK ( TheStreet) -- U.S. regulators rejected Thursday a tamper-resistant painkiller from Pfizer (PFE) and Pain Therapeutics (PTIE), according to U.S. Food and Drug Administration spokesperson Shelly Burgess.

Pain Therapeutics shares were tanking by 32.3% to $6.26, while Pfizer shares were down 0.5% to $20.55.






Southern Union (SUG) soared in premarket trading after receiving an all-cash buyout proposal from Williams (WMB) that values the natural gas pipeline company at $4.9 billion, or $39 a share. Southern Union shares were surging by 15.3% to $39.39.






Boise, Idaho-based Micron Technology (MU) said it earned $75 million, or 7 cents a share, in the three months ended June 2. The average estimate of analysts polled by Thomson Reuters was for a profit of 16 cents a share. Micron shares were plummeting by 10.6% to $7.54.






Enterprise software company Blackboard (BBBB) was popping by 4.2% to $42.50 after the Wall Street journal reported that the enterprise software company is in exclusive talks to be bought by Providence Equity Partners.






Database giant Oracle (ORCL) earned 75 cents a share in the fourth quarter, excluding items, vs. the average analyst estimate of 71 cents a share. However, weak hardware sales pushed the company's stock down 4% to $31.15 in premarket trading.






Management consulting firm Accenture (ACN) was spiking by 3.2% to $57.49 reporting third-quarter profit of 93 cents a share vs. the average analyst estimate of 90 cents a share.






Medical device company Boston Scientific (BSX) was falling 1.4% to $6.99 on news that it was downgraded to neutral from buy at UBS.






Biopharmaceutical company Aegerion Pharmaceuticals (AEGR) said 4.25 million common shares were priced at $15.50 a share. Shares were down 1% to $15.40.






Some of the biggest U.S. states have started antitrust investigations into internet search giant Google (GOOG), adding to the mounting regulatory pressure on the search company as federal authorities move closer to a full-blown inquiry of their own, the Financial Times reported.

Shares were trading sideways at $480.

>>Search for Highest Dividends by Rate or Yield

More on Earnings
Today's Top Earnings
Earnings Calendar

-- Written by Andrea Tse in New York.



>To contact the writer of this article, click here: Andrea Tse.

>To follow the writer on Twitter, go to Andrea Tse.

>To submit a news tip, send an email to: tips@thestreet.com.

Copyright 2011 TheStreet.com Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,677.90 +216.58 1.32%
S&P 500 1,950.82 +23.71 1.23%
NASDAQ 4,452.7920 +69.9450 1.60%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs